Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 26th October 2021
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Dog owners sought for autoimmune disease research
The study will collect information about dogs that have been recently diagnosed with an autoimmune disease.
Study will be the largest of its kind ever conducted in veterinary medicine.

Owners of dogs with autoimmune diseases are being called upon to participate in a vital piece of new research being undertaken by the RVC.

The research will be one of the largest studies of autoimmune diseases ever conducted and aims to collate data and insight into the diagnosis, treatment response and outcomes of dogs with autoimmune conditions.

Results will be distributed among local veterinary practices and specialist hospitals to help owners and vets make informed decisions when their animals are diagnosed.

Dr Barbara Glanemann, lead researcher and senior lecturer in Small Animal Medicine at the RVC, said: “This study will be the first time that the treatment and progress of dogs with autoimmune diseases has been investigated outside universities, providing an essential perspective on the challenges faced by affected dogs and their owners in wider veterinary practice."

The study, named the ImmunoRegistry, has been launched to address the current shortage of information about autoimmune diseases. It will garner information about dogs that have been recently diagnosed with an autoimmune disease, following them for a year in real-time to learn how they respond to treatment.

In total, the team aims to collect information from 400 dogs, making it the largest planned study of autoimmune diseases ever conducted in veterinary medicine globally and providing a crucial resource for future research.

James Swann, a postdoctoral fellow at Columbia University, New York, said: "There is an urgent need to optimise the treatment of dogs with autoimmune diseases, and this study represents an important first step in gathering vital information to make clinical recommendations and guide future research projects.”

For more information about the study, along with the criteria for enrolment, visit rvc.onlinesurveys.ac.uk/immunoregistry

 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.